ENDPOINTS

Lilly-partnered Fauna Bio plans $40M Series A to get into heart failure

MIAMI — Fauna Bio, a biotech that mines data on disease resistance from squirrels and other animals to create new drugs, is looking at raising a Series A to get its first program into clinical trials ...

Mar 14, 2025 - 10:41
 0
Lilly-partnered Fauna Bio plans $40M Series A to get into heart failure
MIAMI — Fauna Bio, a biotech that mines data on disease resistance from squirrels and other animals to create new drugs, is looking at raising a Series A to get its first program into clinical trials ...
Read More

Tags:

Previous Article

Forecasters Warn of ‘Wildfire Outbreak’ Across Texas and Oklahoma

Next Article

Kochi’s vibrant birding community shares its experiences and favourite avian hot...

Related Posts

Lilly says it will invest $27B into US drug manufacturing

Lilly says it will invest $27B into US drug manufacturing

Feb 26, 2025  0

Medicare spending on set of diabetes drugs skyrocketed — report

Medicare spending on set of diabetes drugs skyrocketed ...

Feb 26, 2025  0

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third Harmonic

IN8bio’s Phase 1 AML data; Layoffs at Q32 Bio and Third...

Feb 11, 2025  0